Document is current
Any future updates will be listed below
-
Authors
Wang, Yiping
Fan, Joy Linyue
Melms, Johannes C. https://orcid.org/0000-0002-5410-6586
Amin, Amit Dipak https://orcid.org/0000-0002-2613-2082
Georgis, Yohanna
Barrera, Irving
Ho, Patricia
Tagore, Somnath
Abril-RodrÃguez, Gabriel
He, Siyu
Jin, Yinuo
Biermann, Jana https://orcid.org/0000-0002-8907-4633
Hofree, Matan https://orcid.org/0000-0001-8368-0299
Caprio, Lindsay
Berhe, Simon
Khan, Shaheer A.
Henick, Brian S. https://orcid.org/0000-0003-2681-0805
Ribas, Antoni https://orcid.org/0000-0003-3669-8458
Macosko, Evan Z.
Chen, Fei
Taylor, Alison M.
Schwartz, Gary K.
Carvajal, Richard D.
Azizi, Elham https://orcid.org/0000-0001-5059-6971
Izar, Benjamin https://orcid.org/0000-0003-2379-6702
- License Information
-
More Information
Article History
Received: 22 December 2021
Accepted: 11 November 2022
First Online: 9 January 2023
Competing interests
: B.I. has received consulting fees from Volastra Therapeutics Inc, Merck, AstraZeneca and Janssen Pharmaceuticals and has received research funding to Columbia University from Alkermes, Arcus Biosciences, Checkmate Pharmaceuticals, Compugen, Immunocore and Synthekine. G.A.-R. has received honoraria from consulting with Arcus Biosciences. A.R. has received honoraria from consulting with Amgen, Bristol Myers Squibb, Chugai, Genentech, Merck, Novartis, Roche and Sanofi, is or has been a member of the scientific advisory board and holds stock in Arcus, Compugen, CytomX, Highlight, ImaginAb, Isoplexis, Kite-Gilead, Lutris, Merus, PACT, RAPT, Synthekine and Tango Therapeutics. A.M.T. receives research support from Ono Pharmaceuticals. B.S.H. participated in advisory boards for AstraZeneca and Ideaya. R.D.C. is a consultant for Alkermes, Bristol Myers Squibb, Castle Biosciences, Delcath, Eisai, Hengrui, Ideaya, Immunocore, InxMed, Iovance, Merck, Novartis, Oncosec, Pierre Fabre, PureTech Health, Regeneron, Sanofi Genzyme, Sorrento Therapeutics and Trisalus, serves on clinical/scientific advisory boards for Aura Biosciences, Chimeron and Rgenix Research, and has received research funding to Columbia University from Amgen, Astellis, AstraZeneca, BioMed Valley, Bolt, Bristol Myers Squibb, Corvus, Cstone, Foghorn, Ideaya, Immatics, Immunocore, InxMed, Iovance, Merck, Mirati, Novartis, Pfizer, Plexxikon, Regeneron and Roche/Genentech. B.I. and J.C.M. filed a patent describing the generation of high-quality single-cell genomics data from frozen tissues. The remaining authors declare no competing interests.
